He is currently being evaluated for allogeneic hematopoietic stem cell transplantation (AHSCT).<h4>Conclusion</h4>This case represents one of the youngest patients reported with VEXAS syndrome and provides rare evidence of UBA1 mutation in pulmonary cells, supporting the concept of tissue-level clonal inflammation. This evidence concerns the gene UBA1 and VEXAS syndrome.